Immune mechanism found in osteocyte cells could lead to drug target to prevent spread of cancer to bones medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Frontiers | Nuclear Receptor PXR Confers Irradiation Resistance by Promoting DNA Damage Response Through Stabilization of ATF3 frontiersin.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from frontiersin.org Daily Mail and Mail on Sunday newspapers.
caused quite a bit of pain for him reporter: after standard therapies failed, dr. michael morris tried something new, using a just-approved pet scan to find the prostate cancer cells with a common protein all of these black dots represent islands of cancer. reporter: he then gave rosenbloom six infusions of experimental liquid radiation to seek out the cancer cells and destroy them from within, avoiding healthy cells. this kind of treatment really is specifically going to the prostate cancer cells. reporter: the results out today are promising. the drug reducing the risk of death by 38% and disease progression by 60% does this have the potential to treat men with less severe forms of the disease it absolutely does. reporter: 15 months after the treatment dr. morris still can t find cancer in michael rosenbloom it really gave him his life back. and that s my hope for every patient. reporter: a life rosenbloom is savoring anne thompson, nbc news, new york
patient s own immune system to act on his prostate cancer cells and prevent them from spreading. now, it is just approved by the fda. it is not universally available yet. it is only available in the 50 centers where the trials were conducted with this. i know that in boston, it is available at the leahy clinic and dana farber and i don t know where else in the country it is available. not everybody who wants it or can benefit from it can get it. they only have enough for 2,000 cases. this year. and, the other thing that is so terrible is that the expense of it will be about $93,000. a year. now, medicare has said that they are going to take a year to decide whether to pay for it, some insurance companies are paying for it. you ll have to find out.